Literature DB >> 28079341

Graves’ Disease.

George J Kahaly1, Paul D Olivo2.   

Abstract

Mesh：

Year:  2017        PMID： 28079341     DOI： 10.1056/NEJMc1614624

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema.

Authors:  Changgui Lan; Liping Hu; Chengqi Liao; Yuhong Shi; Yi Wang; Shuanghua Cheng; Wei Huang
Journal:  J Clin Med Res       Date:  2020-11-03

2.  Type 1 diabetes and associated autoimmune diseases.

Authors:  Lara Frommer; George J Kahaly
Journal:  World J Diabetes       Date:  2020-11-15

3.  CD11c+ B Cells Participate in the Pathogenesis of Graves' Disease by Secreting Thyroid Autoantibodies and Cytokines.

Authors:  Yedi Cao; Xue Zhao; Ran You; Yang Zhang; Chenxue Qu; Youyuan Huang; Yang Yu; Yan Gong; Tiechuan Cong; Enmin Zhao; Lanbo Zhang; Ying Gao; Junqing Zhang
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

Review 4.  Thyrotropin Receptor Blocking Antibodies.

Authors:  Tanja Diana; Paul D Olivo; George J Kahaly
Journal:  Horm Metab Res       Date:  2018-10-04       Impact factor: 2.936

5.  Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease.

Authors:  George J Kahaly; Tanja Diana; Michael Kanitz; Lara Frommer; Paul D Olivo
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

6.  2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.

Authors:  George J Kahaly; Luigi Bartalena; Lazlo Hegedüs; Laurence Leenhardt; Kris Poppe; Simon H Pearce
Journal:  Eur Thyroid J       Date:  2018-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.